Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection-Reference-Cited by-同舟云学术

Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection

Published:2022-11 Issue:5 Volume:77 Page:1265-1275
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Sulkowski Mark S.^ORCID,Agarwal Kosh,Ma Xiaoli,Nguyen Tuan T.,Schiff Eugene R.,Hann Hie-Won L.,Dieterich Douglas T.,Nahass Ronald G.,Park James S.^ORCID,Chan Sing,Han Steven-Huy B.,Gane Edward J.,Bennett Michael,Alves Katia,Evanchik Marc,Yan Ran,Huang Qi,Lopatin Uri,Colonno Richard^ORCID,Ma Julie,Knox Steven J.,Stamm Luisa M.^ORCID,Bonacini Maurizio^ORCID,Jacobson Ira M.,Ayoub Walid S.^ORCID,Weilert Frank,Ravendhran Natarajan,Ramji Alnoor,Kwo Paul Yien^ORCID,Elkhashab Magdy,Hassanein Tarek,Bae Ho S.,Lalezari Jacob P.,Fung Scott K.,Yuen Man-Fung^ORCID

Funder

Gilead Sciences

Intercept Pharmaceuticals

Merck

Novartis

Publisher

Elsevier BV

Subject

Hepatology

Reference36 articles.

1. Global hepatitis report 2017,2017

2. Guidelines for the prevention care and treatment of persons with chronic hepatitis B infection,2015